CD14-deficient mice are protected against lipopolysaccharide-induced cardiac inflammation and left ventricular dysfunction

Circulation

Volumn 106, Issue 20, 2002, Pages 2608-2615

  Knuefermann, Pascal ^a   Nemoto, Shintaro ^a   Misra, Arunima ^a   Nozaki, Naoki ^a   Defreitas, Gilberto ^a   Goyert, Sanna M ^a   Carabello, Blase A ^a   Mann, Douglas L ^a   Vallejo, Jesus G ^a  

^a Section of Infectious Diseases   (United States)

Author keywords

Echocardiography; Immune system; Inflammation; Shock

Indexed keywords

CD14 ANTIGEN; CYCLIC GMP; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; INFLAMMATION; MALE; MOUSE; MYOCARDIAL DISEASE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SHOCK;

ANIMALS; ANTIGENS, CD14; CYCLIC GMP; FEMALE; HEART VENTRICLES; HEMODYNAMIC PROCESSES; INFLAMMATION; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIUM; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0037069420     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000038110.69369.4C     Document Type: Article

References (35)

1. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med. 1993;119:771-778.
2. Debets JM, Kampmeijer R, van der Linden MP, et al. Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med. 1989;17:489-494.
3. Parker MM, Shelhamer JH, Bacharach SL, et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med. 1984;100:483-490.
4. Parrillo JE, Burch C, Shelhamer JH, et al. A circulating myocardial depressant substance in humans with septic shock: Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest. 1985;76:1539-1553.
5. Suffredini AF, Fromm RE, Parker MM, et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med. 1989;321:280-287.
6. Jafri SM, Lavine S, Field BE, et al. Left ventricular diastolic function in sepsis. Crit Care Med. 1990;18:709-714.
7. Kumar A, Thota V, Dee L, et al. Tumor necrosis factor α and interleukin 1β are responsible for in vitro myocardial cell depression induced by human shock serum. J Exp Med. 1996;183:949-958.
8. Giroir BP, Johnson JH, Brown T, et al. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest. 1992;90:693-698.
9. Kapadia S, Lee JR, Torre-Amione G, et al. Tumor necrosis factor gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest. 1995;96:1042-1052.
10. Baumgarten G, Knuefermann P, Nozaki N, et al. In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: The role of toll-like receptor-4. J Infect Dis. 2001;183:1617-1624.
11. Nemoto S, Vallejo JG, Knuefermann P, et al. Escherichia coli LPS-induced LV dysfunction: Role of toll-like receptor-4 in the adult heart. Am J Physiol Heart Circ Physiol. 2002;282:H2316-H2323.
12. Wang PY, Kitchens RL, Munford RS. Bacterial lipopolysaccharide binds to CD14 in low-density domains of the monocyte-macrophage plasma membrane. J Inflamm. 1995;47:126-137.
13. Goyert SM, Ferrero E, Rettig WJ, et al. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science. 1988;239:497-500.
14. Haziot A, Rong GW, Bazil V, et al. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor- alpha production by cells in whole blood. J Immunol. 1994;152:5868-5876.
15. Comstock KL, Krown KA, Page MT, et al. LPS-induced TNF-alpha release from and apoptosis in rat cardiomyocytes: Obligatory role for CD14 in mediating the LPS response. J Mol Cell Cardiol. 1998;30:2761-2775.
16. Gangloff SC, Hijiya N, Haziot A, et al. Lipopolysaccharide structure influences the macrophage response via CD14-independent and CD14-dependent pathways. Clin Infect Dis. 1999;28:491-496.
17. Haziot A, Tsuberi BZ, Goyert SM. Neutrophil CD14: Biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide. J Immunol. 1993;150:5556-5565.
18. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science. 1998;282:2085-2088.
19. Hoshino K, Takeuchi O, Kawai T, et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the LPS gene product. J Immunol. 1999;162:3749-3752.
20. Ferrero E, Jiao D, Tsuberi BZ, et al. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc Natl Acad Sci U S A. 1993;90:2380-2384.
21. Haziot A, Ferrero E, Kontgen F, et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity. 1996;4:407-414.
22. Perera PY, Mayadas TN, Takeuchi O, et al. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J Immunol. 2001;166:574-581.
23. Haziot A, Lin XY, Zhang F, et al. The induction of acute phase proteins by lipopolysaccharide uses a novel pathway that is CD14-independent. J Immunol. 1998;160:2570-2572.
24. Manthey CL, Perera PY, Henricson BE, et al. Endotoxin-induced early gene expression in C3H/HeJ (Lpsd) macrophages. J Immunol. 1994;153:2653-2663.
25. Ullrich R, Scherrer-Crosbie M, Bloch KD, et al. Congenital deficiency of nitric oxide synthase 2 protects against endotoxin-induced myocardial dysfunction in mice. Circulation. 2000;102:1440-1446.
26. Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med. 2000;343:338-344.
27. Frantz S, Kobzik L, Kim YD, et al. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest. 1999;104:271-280.
28. Kirschning CJ, Wesche H, Merrill AT, et al. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med. 1998;188:2091-2097.
29. Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 1999;11:443-451.
30. da Silva CJ, Soldau K, Christen U, et al. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex transfer from CD14 to TLR4 and MD-2. J Biol Chem. 2001;276:21129-21135.
31. Dziarski R, Wang Q, Miyake K, et al. MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram- positive and Gram-negative bacteria and their cell wall components. J Immunol. 2001;166:1938-1944.
32. Triantafilou K, Triantafilou M, Dedrick RL. A CD14-independent LPS receptor cluster. Nat Immunol. 2001;2:338-345.
33. Knowlton AA, Kapadia S, Torre-Amione G, et al. Differential expression of heat shock proteins in normal and failing human hearts. J Mol Cell Cardiol. 1998;30:811-818.
34. Fisher CJ Jr, Agosti JM, Opal SM, et al. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein: The Soluble TNF Receptor Sepsis Study Group. N Engl J Med. 1996;334:1697-1702.
35. Verbon A, Dekkers PE, ten Hove T, et al. IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans. J Immunol. 2001;166:3599-3605